Concepedia

Ishan Capila

IC

Statistics

Publications

37

Citations

3.2K

H-Index

22

Active since

1997

Affiliations

Momenta Pharmaceuticals (United States)(Current)

University of Iowa

Massachusetts Institute of Technology

Harvard University

Massachusetts General Hospital

Ishan Capila is an author at Momenta Pharmaceuticals (United States) specializing in life sciences, biochemistry, and glycobiology.

ORCID

Publications per year

1997–2022

37

Publications

37

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

Shiladitya Sengupta, David A. Eavarone, Ishan Capila et al. · Nature · 2005 · 943 citations

, , +16

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 617 citations

, , +7

Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events

Olga Sobolev, Elisa Binda, Sean O’Farrell et al. · Nature Immunology · 2016 · 157 citations · Full text

, , +16

Structural Basis for Interaction of FGF-1, FGF-2, and FGF-7 with Different Heparan Sulfate Motifs<sup>,</sup>

Sheng Ye, Yongde Luo, Weiqin Lu et al. · Biochemistry · 2001 · 150 citations

, , +13

Annexin V–Heparin Oligosaccharide Complex Suggests Heparan Sulfate–Mediated Assembly on Cell Surfaces

Ishan Capila, María J. Hernáiz, Youde Mo et al. · Structure · 2001 · 115 citations · Full text

, , +14

1–5 of 37